anthralin has been researched along with Adenocarcinoma in 1 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raevskaya, AA | 1 |
| Gorbunova, SL | 1 |
| Savvateeva, MV | 1 |
| Severin, SE | 1 |
| Kirpichnikov, MP | 1 |
1 other study available for anthralin and Adenocarcinoma
| Article | Year |
|---|---|
Effect of anthralin on cell viability in human prostate adenocarcinoma.
Topics: Adenocarcinoma; Anthralin; Cell Line, Tumor; Cell Survival; Humans; Male; Prostatic Neoplasms; Serin | 2012 |